Acting through SMAD-dependent or -independent pathways, TGFβ signaling plays a clear role in tumor initiation and progression, invasion and metastatic niche formation, EMT, immune response inhibition, and angiogenesis [18,42]. Here, TGFB1 is linked to neoplasm.